| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |